Back to search results

Phase 2 LiverScope® for Liver Disease Diagnostics

This study is looking at a new, portable device called LiverScope® to help diagnose liver conditions like MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) and NAFLD (Nonalcoholic Fatty Liver Disease). We want to see how well LiverScope® works compared to standard MRI (magnetic resonance imaging) scans, which are commonly used to check on liver health. LiverScope® uses similar technology to an MRI but is smaller and can be used in a doctor's office. We are looking for about 26 participants who are at least 18 years old, have known or suspected MASLD, and have a BMI between 27 and 45. The main goal is to see if LiverScope® measurements match those from a conventional MRI and if the LiverScope® results are consistent over time. This study is currently recruiting.

Study design
This is an observational study involving about 26 participants. It is the second phase of testing for the LiverScope® device.
What's involved
You would undergo a LiverScope® exam, an advanced MRI exam, a blood draw, and have body measurements taken. You would also complete a questionnaire, all within a period of up to 3 months.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for up to 3 months to assess the agreement and consistency of LiverScope® measurements.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07518784

Accurate Point of Care Liver Disease Diagnostics (Phase 2)

Recruiting
Not specifiedAges 18+Observational
University of California, San Diego
~26 participants
Updated 2026-04-09 on ClinicalTrials.gov
What's tested:LiverScope® examMR examBlood drawBody measurementsQuestionnaire

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Agreement of LiverScope® measurements compared to conventional MR
Measured over Up to 3 months
+1 more outcome measured

Conditions

MASLD
MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)
NAFLD
NAFLD (Nonalcoholic Fatty Liver Disease)

Explore related trials

Nonalcoholic Fatty Liver Disease

NCT07518784

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • University of California San Diego

    La Jolla, Californiastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Claude B Sirlin, MD · PRINCIPAL_INVESTIGATOR · University of California, San Diego

Who to contact

Yesenia Covarrubias
[email protected]
858-246-2198
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age ≥ 18 years
Known or clinically suspected MASLD
BMI greater than 27 kg/m\^2 and less than 45 kg/m\^2 at the time of referral
Ability to lie on LiverScope® device table for about 60 minutes
Ability to hold breath repeatedly for about 20 seconds during MR and LiverScope® exams
Willing and able to undergo all study procedures

Exclusion

UCSD study personnel or Livivos study personne
Contraindications to MR
Potential participant states that she knows that she is pregnant, thinks she may be pregnant, or states that she is trying to become pregnant.
Known chronic liver disease other than MASLD

What this trial measures

  • Agreement of LiverScope® measurements compared to conventional MRUp to 3 months

    Assessment of agreement between LiverScope® measurements and conventional MR measurements in the liver.

  • Repeatability and reproducibility of LiverScope® measurementsUp to 3 months

    Estimation of repeatability and reproducibility coefficients of liver measurements made by LiverScope®.